Osteoporosis in CKD — SCE Endocrinology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Specialist bone review before antiresorptive selection
Advanced CKD complicates antiresorptive choice because bone turnover and hypocalcaemia risks vary. Specialist review helps distinguish osteoporosis from CKD-MBD and select safe therapy. Reflux intolerance also makes oral bisphosphonate use poor practice.
Reference: NICE CG146; NOGG Guideline; KDIGO CKD-MBD